VANCOUVER, British Columbia, May 26, 2011 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today that it will present data demonstrating its ongoing lipid nanoparticle (LNP) technology innovations at a scientific symposium taking place May 24 – 27, 2011 in Montreal, Quebe
